148 related articles for article (PubMed ID: 15517745)
1. The release of zinc ions from and cytocompatibility of two zinc oxide dressings.
Agren MS; Mirastschijski U
J Wound Care; 2004 Oct; 13(9):367-9. PubMed ID: 15517745
[TBL] [Abstract][Full Text] [Related]
2. [Effects of the zinc oxide and cod liver oil containing ointment Zincojecol in an animal model of wound healing].
Kietzmann M; Braun M
Dtsch Tierarztl Wochenschr; 2006 Sep; 113(9):331-4. PubMed ID: 17009808
[TBL] [Abstract][Full Text] [Related]
3. Innovations in bandage technology: SSL's non-fray Steripaste.
Lindsay E
Br J Nurs; 1999 Oct 28-Nov 10; 8(19):1315, 1318-9. PubMed ID: 10887810
[TBL] [Abstract][Full Text] [Related]
4. Phosphate-enhanced cytotoxicity of zinc oxide nanoparticles and agglomerates.
Everett WN; Chern C; Sun D; McMahon RE; Zhang X; Chen WJ; Hahn MS; Sue HJ
Toxicol Lett; 2014 Feb; 225(1):177-84. PubMed ID: 24362007
[TBL] [Abstract][Full Text] [Related]
5. Effect of Postoperative Dressing on Excisions Performed on the Leg: A Comparison Between Zinc Oxide Compression Dressings Versus Standard Wound Care.
Thompson CB; Wiemken TL; Brown TS
Dermatol Surg; 2017 Nov; 43(11):1379-1384. PubMed ID: 28654576
[TBL] [Abstract][Full Text] [Related]
6. Paste-impregnated bandages.
Eagle M
J Wound Care; 1999 Jun; 8(6):300-1. PubMed ID: 10776214
[No Abstract] [Full Text] [Related]
7. Examining the range of medicated and paste-impregnated bandages.
Williams C
Br J Nurs; 1999 Aug 12-Sep 8; 8(15):1019-20. PubMed ID: 10711033
[TBL] [Abstract][Full Text] [Related]
8. Topical insulin in wound healing: a randomised, double-blind, placebo-controlled trial.
Greenway SE; Filler LE; Greenway FL
J Wound Care; 1999 Nov; 8(10):526-8. PubMed ID: 10827659
[TBL] [Abstract][Full Text] [Related]
9. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
[TBL] [Abstract][Full Text] [Related]
10. An appraisal of povidone-iodine and wound healing.
Goldenheim PD
Postgrad Med J; 1993; 69 Suppl 3():S97-105. PubMed ID: 8290466
[TBL] [Abstract][Full Text] [Related]
11. Studies on zinc in wound healing.
Agren MS
Acta Derm Venereol Suppl (Stockh); 1990; 154():1-36. PubMed ID: 2275309
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous absorption of zinc from zinc oxide applied topically to intact skin in man.
Agren MS
Dermatologica; 1990; 180(1):36-9. PubMed ID: 2307275
[TBL] [Abstract][Full Text] [Related]
13. Common cosmeceuticals.
Bissett DL
Clin Dermatol; 2009; 27(5):435-45. PubMed ID: 19695474
[TBL] [Abstract][Full Text] [Related]
14. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
Realdon N; Tagliaboschi A; Perin F; Ragazzi E
Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
[TBL] [Abstract][Full Text] [Related]
15. Trophic skin ulceration in leprosy: evaluation of the efficacy of topical phenytoin sodium zinc oxide paste.
Sehgal VN; Prasad PV; Kaviarasan PK; Rajan D
Int J Dermatol; 2014 Jul; 53(7):873-8. PubMed ID: 24601869
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of topical zinc oxide application on hypertrophic scar development in rabbits.
Aksoy B; Atakan N; Aksoy HM; Tezel GG; Renda N; Ozkara HA; Onder E
Burns; 2010 Nov; 36(7):1027-35. PubMed ID: 20381965
[TBL] [Abstract][Full Text] [Related]
17. [Ointments. 3. Liberation and absorption of medicinal substances from ointment bases and the factors that influence the therapeutic efficacy of oitments].
Pertsev IM; Bashura GS; Salo DP; Muraviov IO; Pimenov OA
Farm Zh; 1972; 27(3):18-25. PubMed ID: 4662808
[No Abstract] [Full Text] [Related]
18. [Effect of technological factors on the anti-inflammatory action of zinc ointment].
Ponomarev VD; Kuiantseva AM; Inzhechik TV
Farmatsiia; 1975; 24(5):9-12. PubMed ID: 1225643
[No Abstract] [Full Text] [Related]
19. Herbal preparation extract for skin after radiotherapy treatment. Part One--Preclinical tests.
Skalska-Kamińska A; Woźniak A; Paduch R; Kocjan R; Rejdak R
Acta Pol Pharm; 2014; 71(5):781-8. PubMed ID: 25362806
[TBL] [Abstract][Full Text] [Related]
20. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
Yakubu R; Peh KK; Tan YT
Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
